# Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults

> **NCT01846104** · PHASE1 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 4 (actual)

## Conditions studied

- Ricin Poisoning

## Interventions

- **BIOLOGICAL:** 50-μg booster dose RVEc

## Key facts

- **NCT ID:** NCT01846104
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-30
- **Primary completion:** 2013-06-30
- **Final completion:** 2013-06-30
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2019-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01846104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01846104, "Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01846104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*